Company / EPS (Basic)
Illumina, Inc. EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$7.34
FY2025
5-year range
-$28.00 / $6.81
FY2021-FY2025
Trend
+73.8%
vs FY2024
Sector context
#153 of 160
Health Care
What the data says
Among 160 Health Care companies, Illumina, Inc. is in the bottom 4% for eps (basic). EPS (Basic) has fluctuated over the past 10 years, ranging from $-28.00 in FY2024 to $6.81 in FY2021.
Based on SEC 10-K filings.
-7.34 in FY2025.
Declined from $5.07 to $-7.34 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 160This company -$7.34 Sector average $1.69
▼
-535.4% below sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 73.8% year-over-year.
- Ranks #153 out of 160 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2021.
- Lowest eps (basic) in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 29.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$7.34 | +73.8% |
| FY2024 | -$28.00 | -652.3% |
| FY2023 | $5.07 | +13.2% |
| FY2022 | $4.48 | -34.2% |
| FY2021 | $6.81 | +21.0% |
| FY2020 | $5.63 | +13.5% |
| FY2019 | $4.96 | +60.5% |
| FY2018 | $3.09 | -3.1% |
| FY2017 | $3.19 | +22.2% |
| FY2016 | $2.61 | +161.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026